Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
insulin human winthrop
sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drogi użati fid-dijabete - dijabete mellitus fejn huwa meħtieġ it-trattament bl-insulina. insulina bniedem winthrop mgħaġġla huwa wkoll adattat għat-trattament ta ' koma hyperglycaemic u ketoacidosis, kif ukoll għall-kisba minn qabel, intra - u postoperative stabbilizzazzjoni fil-pazjenti bl-diabetes mellitus.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
insuman
sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drogi użati fid-dijabete - dijabete mellitus fejn huwa meħtieġ it-trattament bl-insulina. insuman rapid huwa wkoll adattat għall-kura ta 'koma ipergliċemika u ketoaċidożi, kif ukoll għall-kisba ta' stabilizzazzjoni minn qabel, intra u wara l-operazzjoni f'pazjenti bid-dijabete mellitus.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
actrapid
novo nordisk a/s - insulina umana - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
inpremzia
baxter holding b.v. - insulin human (rdna) - diabetes mellitus - drogi użati fid-dijabete - inpremzia is indicated for the treatment of diabetes mellitus.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
velosulin
novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
solumarv
marvel lifesciences ltd - insulina umana - diabetes mellitus - it-trattament tad-dijabete.